Denali Therapeutics Inc. ($DNLI)
Filing Information
| Accession Number | 0001724311-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document Date | Jan 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
230,800
Total Value
$0.00
P&L
+inf% (+$4,747,556.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COFO and Secretary | Common Stock | โ | Jan 3, 2026 | Grant/Award | 57,700 | $0.00 | $0.00 | 300,046 | Direct | โ | View Details | |
COFO and Secretary | Stock Option (right to buy) | Derivative | Jan 3, 2026 | Grant/Award | 173,100 | $0.00 | $0.00 | 173,100 | Direct | โ | View Details |